-
...
-
Please click on link below for webcast of presentation by Michael Hunt, CEO at the 2011 Stem Cell on the Mesa Conference, La Jolla, CA, USA on 1st December 2011
http://app.wistia.com/embed/medias/e9611ffada?width=640&height=360&autoplay=false&...
-
Guildford, UK, 6 December 2011: ReNeuron welcomes the announcement by the Prime Minister of a coordinated life sciences strategy to provide a foundation for the future of the bioscience sector in the UK. ...
-
Guildford, UK, 28 November 2011: ReNeuron provides an update on progress with the PISCES (Pilot Investigation of Stem Cells in Stroke) clinical trial of its ReN001 stem cell therapy for disabled stroke patients.
...
-
Please click on link below for webcast of 2011 Interim Results presentation to analysts.
http://media.buchanan.uk.com/reneuron281111/index.html
...
-
Guildford, UK: 28 November 2011
ReNeuron announces Interim Results for the six months ended 30 September 2011
Full details can be downloaded below:
...
-
Guildford, UK, 9 November 2011: ReNeuron provides an update on progress with the PISCES Phase I clinical trial of its ReN001 stem cell therapy for disabled stroke patients, and confirms the date for its 2011 interim results statement, being Mond...
-
Guildford, UK, 10 October 2011: ReNeuron announces that the Company will be presenting at Daniel Stewart & Company’s Stem Cell Technology Conference, to be held in London on Wednesday 19 October 2011. &nb...
-
Guildford, UK, 15 September 2011: ReNeuron announces that all resolutions put to shareholders at its Annual General Meeting were passed ...
-
Guildford, UK, 15 September 2011: ReNeuron provides a trading update ahead of its Annual General Meeting ...
-
Guildford, UK, 13 September 2011: ReNeuron provides an update on progress with the PISCES Phase I clinical trial of its ReN001 stem cell therapy for disabled stroke patients.
...
-
Guildford, UK, 1 September 2011: ReNeuron provides an update on progress with the PISCES Phase I clinical trial of its ReN001 stem cell therapy for disabled stroke patients
...
-
Guildford, UK, 29 July 2011: ReNeuron announces that its Annual Report and Accounts for the year ended 31 March 2011 and the Notice of the 2011 Annual General Meeting (AGM) have been sent to shareholders and are also available on the Company's websit...
-
Guildford, UK, 20 July 2011: ReNeuron announces that it is strengthening its Board by the appointments of John Edward Berriman and Simon Christopher Cartmell as non-executive directors of the Company with immediate effect.
...
-
Please click on link below for webcast of 2011 Preliminary results presentation to analysts. .
http://mediaserve.buchanan.uk....
-
Guildford, UK, 5 July 2011: ReNeuron announces that it has signed a new contract with Angel Biotechnology for development and GMP (Good Manufacturing Practice) manufacturing services in support of its development programme for its ReN001 stem cell th...
-
Guildford, UK, 30 June 2011: ReNeuron announces Preliminary Results for the Year Ended March 2011
...
-
Guildford, UK, 24 June 2011: ReNeuron announces that it is launching a newly designed corporate website. The website has enhanced layout and content, reflecting the Company’s progress, ambition and leading position in the development of novel stem...
-
Guildford, UK, 16 June 2011: ReNeuron Group plc (LSE: RENE.L) (“ReNeuron” or the “Company”) announces that it has signed a patent and know-how license agreement with Schepens Eye Research Institute (“Schepens”), Boston, US, regarding the Compa...
-
Guildford, UK, 27 May 2011: ReNeuron Group plc (LSE: RENE.L) is pleased to announce the completion of dosing of the first cohort of patients in the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients. The PISCES study (Pilot...
